Today: 25 January 2026
Subscribe
Browse Category

Mergers and Acquisitions News 7 January 2026 - 24 January 2026

Beazley shares rise again as Zurich bid deadline nears — what to watch when London reopens

Beazley shares rise again as Zurich bid deadline nears — what to watch when London reopens

LONDON, Jan 24, 2026, 07:46 GMT — Market closed Beazley Plc shares ended Friday 3.23% higher at 11.52 pounds, outpacing a flat London market. Investors remained focused on the Zurich takeover saga heading into the weekend. (MarketWatch) The stock is still far off Zurich Insurance Group’s recent 1,280 pence-per-share offer, leaving a significant gap. Traders are set to probe that…
24 January 2026
····
Kenvue (KVUE) stock price barely budges as Kimberly-Clark deal vote nears

Kenvue (KVUE) stock price barely budges as Kimberly-Clark deal vote nears

New York, Jan 23, 2026, 15:07 EST — Regular session Kenvue Inc shares edged up 0.1% to $17.77 on Friday, tracking closely with a flat tape and a small dip in would-be buyer Kimberly-Clark. The stock has become a referendum on timing and odds ahead of the companies’ Jan. 29 shareholder meetings, where investors will vote on proposals needed to…
23 January 2026
······
Netflix flips to an all-cash $82.7 billion Warner Bros. Discovery bid as Paramount clock ticks

Netflix flips to an all-cash $82.7 billion Warner Bros. Discovery bid as Paramount clock ticks

LOS ANGELES, January 20, 2026, 05:32 (PST) Netflix has shifted to an all-cash bid for Warner Bros. Discovery’s studio and streaming units, keeping the price steady at $82.7 billion in a move to edge out Paramount Skydance. The updated offer would pay Warner shareholders $27.75 per share, according to a filing on Tuesday. (Reuters) The move comes just a day…
20 January 2026
······
Kenvue stock edges up as Kimberly-Clark vote nears — the deal spread traders are watching

Kenvue stock edges up as Kimberly-Clark vote nears — the deal spread traders are watching

New York, Jan 14, 2026, 11:12 EST — Regular session Kenvue Inc shares ticked up roughly 0.4% to $17.08 on Wednesday, continuing a stretch of modest fluctuations as the stock moves mainly on deal speculation. The gain followed Kimberly-Clark’s submission of extra documents to the U.S. Securities and Exchange Commission related to its intended purchase of the consumer health firm.…
14 January 2026
······
Netflix stock slips as all-cash Warner Bros bid talk swirls, with earnings days away

Netflix stock slips as all-cash Warner Bros bid talk swirls, with earnings days away

New York, January 14, 2026, 10:49 (EST) — Regular session Netflix shares dropped 1.6% Wednesday morning amid new developments in its pursuit of Warner Bros Discovery’s studio and streaming units. Warner Bros stock held steady, while Paramount Skydance slipped roughly 0.6%. (Reuters) This report matters now because the battle has become a test of structure: how much cash Netflix is…
14 January 2026
·······
Glencore stock steady as Rio Tinto lines up banks for possible takeover

Glencore stock steady as Rio Tinto lines up banks for possible takeover

London, 14 Jan 2026, 08:16 GMT — Regular session Glencore plc (GLEN.L) held steady at 470.2 pence in early London trading Wednesday, reflecting last week’s takeover rumors already baked into the price. (Glencore) Rio Tinto has tapped JPMorgan, Evercore, and Macquarie to advise on a possible Glencore takeover, according to a source close to the matter who spoke to Reuters.…
14 January 2026
······
Amphenol stock rises as Barclays, Citi and Truist lift targets after CommScope deal closes

Amphenol stock rises as Barclays, Citi and Truist lift targets after CommScope deal closes

New York, January 13, 2026, 14:25 EST — Regular session Amphenol Corp shares climbed 2.2%, hitting $148.28 in afternoon trading Tuesday, defying the broader market slump. The S&P 500 ETF SPY and the tech-focused QQQ both slipped roughly 0.4%. The connector maker has been on the rise after finalizing its $10.5 billion acquisition of CommScope and as analysts updated their…
13 January 2026
·····
GSK stock in focus: JPMorgan healthcare agenda, merger chatter and key dates for investors

GSK stock in focus: JPMorgan healthcare agenda, merger chatter and key dates for investors

London, January 12, 2026, 08:41 GMT — Regular session Shares of GSK plc edged down 0.03% to 1,885.5 pence early Monday in London, after fluctuating between 1,870.5 and 1,885.5 pence during the session. The annual J.P. Morgan Healthcare Conference takes place January 12–15 in San Francisco. According to the agenda, GSK is scheduled for a 7:30 a.m. Pacific slot on…
12 January 2026
······
Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus

Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus

New York, Jan 9, 2026, 20:01 (EST) — Market closed. Merck & Co (MRK.N) shares slipped on Friday following reports that the pharma giant is in talks to acquire cancer-focused biotech Revolution Medicines (RVMD.O) for as much as $32 billion. Merck ended the day down 0.4% at $110.53, after swinging between $110.26 and $112.46. (Reuters) The possible bid comes as…
10 January 2026
·····
D-Wave Quantum stock (QBTS) slides after $550 million Quantum Circuits deal puts dilution in focus

D-Wave Quantum stock (QBTS) slides after $550 million Quantum Circuits deal puts dilution in focus

New York, January 7, 2026, 20:16 (EST) — Market closed D-Wave Quantum shares fell 3.4% to close at $30.20 on Wednesday after the quantum computing company announced a $550 million deal for Quantum Circuits. StockAnalysis The move matters now because D-Wave is trying to widen its pitch beyond quantum annealing — a specialised method used mainly for optimisation problems such…
8 January 2026
·····
Merck stock slips after Cidara tender offer; $9 billion R&D hit and HPV schedule shift in focus

Merck stock slips after Cidara tender offer; $9 billion R&D hit and HPV schedule shift in focus

New York, Jan 7, 2026, 15:40 (EST) — Regular session Merck & Co (MRK.N) shares were down about 0.3% at $108.59 in afternoon trade on Wednesday after the drugmaker said it had completed its cash tender offer for Cidara Therapeutics (CDTX.O) and expected to finish the acquisition through a merger later in the day. The company said the deal will…
7 January 2026
···
Ventyx Biosciences stock jumps premarket as Eli Lilly buyout talks fuel takeover buzz

Ventyx Biosciences stock jumps premarket as Eli Lilly buyout talks fuel takeover buzz

New York, Jan 7, 2026, 05:03 EST — Premarket Ventyx Biosciences shares jumped about 66% before the bell on Wednesday after a report that Eli Lilly is in advanced talks to buy the biotech company for more than $1 billion. The stock traded at $16.70 in premarket action, versus a $10.05 regular-session close. Public The move matters because a confirmed…
7 January 2026
····
1 2 3 … 9

Stock Market Today

  • 5 Reasons Income Investors Should Consider Realty Income High-Yield Dividend Stock
    January 25, 2026, 6:26 AM EST. Realty Income (O) stands out for income investors seeking high dividend yields, offering a forward yield above 5.2% backed by a solid real estate investment trust (REIT) business model that requires distributing 90% of income as dividends. It boasts a 30-year track record of dividend increases, with 133 raises since 1994 and 112 consecutive quarterly hikes. The REIT pays dividends monthly, branded as 'The Monthly Dividend Company,' providing consistent cash flow. Realty Income delivers stability with 29 years of positive operational returns and a diversified portfolio of 15,500 properties across 92 industries, shielding it from market volatility. Finally, it presents attractive growth opportunities for investors seeking income plus capital appreciation potential.
Go toTop